Victoria Chapman Selected Research

CRA 013783

11/2018

Analgesic effects of the cathepsin K inhibitor L-006235 in the monosodium iodoacetate model of osteoarthritis pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Victoria Chapman Research Topics

Disease

46	Pain (Aches) 10/2022 - 02/2002
17	Osteoarthritis 10/2022 - 01/2008
15	Inflammation (Inflammations) 10/2022 - 05/2002
13	Chronic Pain 10/2022 - 08/2007
11	Neuralgia (Stump Neuralgia) 10/2020 - 02/2002
10	Hyperalgesia 01/2018 - 12/2005
6	Hypersensitivity (Allergy) 11/2021 - 12/2005
5	Knee Osteoarthritis 01/2022 - 09/2011
3	Arthralgia (Joint Pain) 01/2022 - 11/2011
3	Synovitis 01/2020 - 09/2014
2	Osteophyte 11/2018 - 08/2014
2	Gliosis 01/2017 - 01/2013
1	Migraine Disorders (Migraine) 10/2022
1	Neurogenic Inflammation 10/2022
1	Long Term Adverse Effects 01/2022
1	COVID-19 01/2022
1	Cognitive Dysfunction 09/2017

Drug/Important Bio-Agent (IBA)

22	Analgesics (Analgesic Drugs)IBA 01/2022 - 12/2006
15	EndocannabinoidsIBA 11/2017 - 12/2006
12	Iodoacetic AcidIBA 11/2021 - 11/2011
12	CannabinoidsIBA 09/2017 - 02/2002
10	CarrageenanIBA 11/2020 - 08/2003
5	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 10/2012 - 12/2006
4	LipidsIBA 01/2022 - 04/2013
4	CB2 Cannabinoid ReceptorIBA 01/2013 - 11/2004
3	Nerve Growth Factor (NGF)IBA 10/2022 - 09/2014
3	Opioid Analgesics (Opioids)IBA 10/2022 - 11/2021
3	CollagenIBA 01/2021 - 06/2015
3	Phosphotransferases (Kinase)IBA 01/2020 - 09/2014
3	TropomyosinIBA 01/2020 - 09/2014
3	Pharmaceutical PreparationsIBA 11/2018 - 10/2012
3	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2016 - 08/2003
3	1,1-dimethylbutyl-1-deoxy-Delta(9)-THCIBA 01/2013 - 11/2004
3	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 10/2012 - 07/2008
3	anandamide (arachidonylethanolamide)IBA 10/2012 - 07/2008
3	Cannabinoid Receptors (Cannabinoid Receptor)IBA 10/2012 - 01/2008
3	Cannabinoid Receptor AgonistsIBA 12/2005 - 02/2002
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2022 - 01/2020
2	Biological ProductsIBA 01/2022 - 09/2013
2	Epoxide HydrolasesIBA 01/2022 - 01/2018
2	LigandsIBA 11/2021 - 04/2013
2	Calcitonin Gene-Related PeptideIBA 11/2020 - 06/2015
2	Messenger RNA (mRNA)IBA 10/2020 - 01/2013
2	salicylhydroxamic acid (SHAM)IBA 01/2020 - 11/2004
2	AcidsIBA 01/2017 - 09/2014
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2017 - 07/2008
2	Transient Receptor Potential ChannelsIBA 01/2017 - 09/2011
2	MJN110IBA 11/2016 - 09/2013
2	Capsaicin (Zostrix)FDA Link 01/2016 - 12/2006
2	Diphosphonates (Bisphosphonates)IBA 08/2014 - 01/2011
2	EnzymesIBA 09/2013 - 12/2012
2	CytokinesIBA 01/2013 - 09/2011
2	nimesulide (Aulin)IBA 11/2011 - 07/2008
2	Minocycline (Cyclops)FDA LinkGeneric 11/2011 - 07/2009
1	Substance PIBA 10/2022
1	14,15-dihydroxyeicosatrienoic acidIBA 01/2022
1	Naloxone (Narcan)FDA LinkGeneric 11/2021
1	Morphine (MS Contin)FDA LinkGeneric 11/2021
1	Serine (L-Serine)FDA Link 11/2021
1	EndorphinsIBA 11/2021
1	Amino Acids FDA Link 01/2021
1	Pyruvic Acid (Pyruvate)IBA 01/2021
1	Freund's AdjuvantIBA 11/2020
1	LectinsIBA 11/2020
1	AMPA Receptors (AMPA Receptor)IBA 11/2019
1	PropionatesIBA 11/2019
1	CalciumIBA 11/2019
1	Glutamate Receptors (Glutamate Receptor)IBA 11/2019
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 11/2019
1	Glial Fibrillary Acidic ProteinIBA 03/2019
1	Pain-FreeIBA 03/2019
1	2'-deoxyadenosineIBA 01/2019
1	cordycepinIBA 01/2019
1	mRNA Cleavage and Polyadenylation FactorsIBA 01/2019
1	Cathepsin KIBA 11/2018
1	CRA 013783IBA 11/2018
1	OxylipinsIBA 01/2018
1	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2018
1	Ala(2)-MePhe(4)-Gly(5)- Enkephalin (DAGO)IBA 01/2018
1	Opioid Peptides (Opioid Peptide)IBA 11/2017
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	Therapeutic UsesIBA 01/2017
1	17- hydroxy- 4,7,10,13,15,19- docosahexaenoic acidIBA 01/2017
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 01/2017
1	resolvin D2IBA 01/2017
1	MonoglyceridesIBA 11/2016
1	Lipase (Acid Lipase)FDA Link 11/2016
1	Monoacylglycerol LipasesIBA 11/2016
1	cathepsin SIBA 04/2016
1	3- (5- (2,3- dichlorophenyl)- 1H- tetrazol- 1- yl)methylpyridineIBA 04/2016
1	trkA ReceptorIBA 01/2016
1	olvanilIBA 01/2016
1	resolvin D1IBA 01/2016

Therapy/Procedure

7	Intra-Articular Injections 01/2020 - 12/2010
4	Therapeutics 01/2022 - 09/2014
4	Analgesia 11/2021 - 01/2008
2	Ligation 07/2009 - 12/2006
1	Drug Therapy (Chemotherapy) 10/2020
1	Transcutaneous Electric Nerve Stimulation (TENS) 01/2016